Following the proposal of typical, atypical, and combined cases of PSP by Lantos [26], Williams et al. provided evidence for biochemical and tau pathology load differences between PSP with Parkinsonism (PSP-P) and the classical clinical phenotype Richardson syndrome (PSP-RS) [47, 48]. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.